Family Study of Lymphoproliferative Disorders

This observational study is looking into how genetics and environmental factors might lead to blood and lymph node cancers, such as lymphoma and leukemia. Researchers want to understand why these cancers sometimes run in families. You may be able to join if you are between 18 and 100 years old and have at least two living, blood-related family members who have been diagnosed with a lymphoproliferative disorder (a condition where certain white blood cells grow too much). The study aims to measure the ongoing risk of developing blood or lymphoma cancers. The current recruitment status is unclear.

Study design
This is an observational study that plans to enroll 3000 participants.
What's involved
Not specified in the trial record.
Compensation
Not stated in the trial record.
Follow-up
The primary endpoint, risk of blood or lymphoma, is measured at ongoing.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT00626496

Family Study of Lymphoproliferative Disorders

Recruiting
Not specifiedAges 18+Observational
Mayo Clinic
~3,000 participants
Updated 2025-10-14 on ClinicalTrials.gov

At a glance

Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Risk of blood or lymphoma
Measured over Ongoing
Lymphoma, Non-Hodgkin
Leukemia, Lymphocytic, Chronic, B-Cell
Lymphoma, B-Cell
Monoclonal B-Cell Lymphocytosis
Multiple Myeloma
1 sites across 1 states
Minnesota1
  • Susan Slager, Ph.D. · PRINCIPAL_INVESTIGATOR · Mayo Clinic

Opens a ready-to-send draft in your own email app — review before sending.

  • Risk of blood or lymphomaOngoing